Abstract:Aim: Gambogic acid (GA) is the major active compound of Gamboge, a brownish or orange resin exuded from Garcinia hanburryi tree in Southeast Asia. Previous studies have demonstrated that GA exhibits potent anticancer effects by inducing cell cycle arrest or apoptosis in many types of cancer cell lines and blocking angiogenesis via inhibition of vascular endothelial cell proliferation and migration. Proliferation and migration of vascular smooth muscle cells (VSMCs) are critical steps in the progress of atherosclerosis and restenosis after angioplasty. In the present study, we investigated whether GA has an inhibitory effect on the proliferation and migration of VSMCs and its possible mechanism.Methods: The inhibitory effect of GA on the proliferation induced by PDGF-BB and EGF was measured by using Cell number counting assay and [H-3]-thymidine incorporation. The effects of GA on the cell cycle progression and viability stimulated by PDGF-BB and EGF were also analyzed by flow cytometry analysis. The inhibitory effect of GA on the migration stimulated by PDGF-BB was measured by transwell chamber assay. The effect of GA on the Cell cycle regulatory molecules (cyclinD1, cyclinE, CDK2, CDK4), PDGFR and its downstream signaling molecules including ERK1/2, PLC.1, AKT and JNK was measured by western blotting. The effect of GA on the Rac1 activity was measured by using GST-pulldown assay. The effects of GA on the tyrosine phosphorylation stimulated by PDGF-BB and EGF and the capacity of GA binding with PDGF-BB and EGF were also measured.Results: We found that GA significantly inhibited proliferation, migration and DNA synthesis in primary cultured rat aortic VSMCs at concentrations of 0.25, 0.5, 1.0 and 2.0 mu mol/L after stimulation of 50 mu g/L platelet-derived growth factor-BB (PDGF-BB). GA induced G0/G1 phase arrest in the cell cycle progression of VSMCs. No obvious necrosis or apoptosis was found with GA treatment. The expressions of CDK2, CDK4, cyclin D1 and cyclin E, cell cycle regulatory molecules, were significantly suppressed by GA treatment in a concentration-dependent manner. The phosphorylation of PDGF receptor beta (PDGFR-beta) and the activities of downstream intracellular signaling molecules including phospho-ERK, phospho-PLC gamma 1, phospho-AKT, phospho-JNK and GTP-Rac1 were also inhibited by GA pretreatment. GA inhibited PDGFR-beta phosphorylation through inhibiting the activity of tyrosine directly, rather than indirectly via binding PDGF-BB.Conclusions: The results of this study provide preliminary evidence that the inhibitory effects of GA on VSMCs proliferation and migration may be mediated through multiple signal pathways controlled by PDGF-R beta activation and its downstream intracelluar signaling.

Gambogic Acid Inhibits Cell Proliferation via Suppressing Epithelial Growth Factor Receptor Tyrosine Phosphorylation in Rat Aortic Smooth Muscle Cell

Gambogic Acid Induces G0/G1 Cell Cycle Arrest and Cell Migration Inhibition Via Suppressing PDGF Receptor Β Tyrosine Phosphorylation and Rac1 Activity in Rat Aortic Smooth Muscle Cells.

Gambogic Acid Inhibits Angiogenesis Through Suppressing Vascular Endothelial Growth Factor-Induced Tyrosine Phosphorylation of Kdr/Flk-1

Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells.

Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.

[Effect of gambogic acid on proliferation of SKM-1 cells and its mechanism].

Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling.

Anti-Invasive Effect Of Gambogic Acid In Mda-Mb-231 Human Breast Carcinoma Cells

Gambogic acid impairs tumor angiogenesis by targeting YAP/STAT3 signaling axis.

Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II.

Proteomic and Bioinformatic Analyses of Possible Target-Related Proteins of Gambogic Acid in Human Breast Carcinoma MDA-MB-231 Cells.

Effect of Gambogic Acid on Growth Activity and Invasion in Renal Carcinoma 786-O Cells

Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting.

Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study.

Gambogic Acid Affects ESCC Progression Through Regulation of PI3K/AKT/mTOR Signal Pathway

Gambogic Acid Suppresses Cancer Invasion and Migration by Inhibiting TGFβ1-induced Epithelial-to-mesenchymal Transition.

Regulation of Gambogic Acid on Herg Potassium Channel Protein of K562 Leukemia Cells

Effect of Gambogic Acid on the Proliferation of Human Colon Carcinoma Cell SW480 and the Expression of VEGFR2

Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis

Gambogic Acid Suppresses Hypoxia-Induced Hypoxia-Inducible Factor-1Α/vascular Endothelial Growth Factor Expression Via Inhibiting Phosphatidylinositol 3-Kinase/akt/mammalian Target Protein of Rapamycin Pathway in Multiple Myeloma Cells.

Effect of Gastrodin on Rat Vascular Smooth Muscle Cell Migration Induced by Platelet-Derived Growth Factor-Bb